The Bubonic Plague, Scientific American, vol.258, issue.2, pp.118-123, 1988. ,
DOI : 10.1038/scientificamerican0288-118
Pharaonic Egypt and the origins of plague, Journal of Biogeography, vol.202, issue.2, pp.269-276, 2004. ,
DOI : 10.1046/j.0305-0270.2003.01009.x
Bubonic plague in biblical times, J R Soc Med, vol.936, p.449, 2000. ,
Bubonic plague in the Book of Samuel, Journal of the Royal Society of Medicine, vol.98, issue.9, p.436, 2005. ,
DOI : 10.1258/jrsm.98.9.436
Treatments for bubonic plague: reports from seventeenth century British epidemics, J R Soc Med, vol.938, pp.322-324, 2000. ,
Treatment of Plague with Gentamicin or Doxycycline in a Randomized Clinical Trial in Tanzania, Clinical Infectious Diseases, vol.42, issue.5, pp.614-621, 2006. ,
DOI : 10.1086/500137
The Genomes On Line Database (GOLD) in 2007: status of genomic and metagenomic projects and their associated metadata, Nucleic Acids Research, vol.36, issue.Database, pp.475-479, 2008. ,
DOI : 10.1093/nar/gkm884
Conservation and Divergence Among Salmonella enterica Subspecies, Infectious Disorders - Drug Targets, vol.9, issue.3, 2009. ,
DOI : 10.2174/1871526510909030248
Evolutionary divergence of Plasmodium falciparum: Sequences, protein-protein interactions, pathways and processes, Infectious Diseases -Drug Targets, vol.12, 2009. ,
The euHCVdb Suite of In Silico Tools for Investigating the Structural Impact of Mutations in Hepatitis C Virus Proteins, Infectious Disorders - Drug Targets, vol.9, issue.3, 2009. ,
DOI : 10.2174/1871526510909030272
Drug Design Strategies for Targeting G-Protein-Coupled Receptors, ChemBioChem, vol.3, issue.10, pp.928-944, 2002. ,
DOI : 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5
Transmembrane protein structures without X-rays, Trends in Biochemical Sciences, vol.31, issue.2, pp.106-113, 2006. ,
DOI : 10.1016/j.tibs.2005.12.005
ChemInform Abstract: Homology Model-Based Virtual Screening for GPCR Ligands Using Docking and Target-Biased Scoring., ChemInform, vol.48, issue.33, pp.1104-1117, 2008. ,
DOI : 10.1002/chin.200833221
structure and interactions with Inhibitors A structural model of a seven-transmembrane helix receptor: the Duffy antigen/receptor for chemokine (DARC) New assessment of a structural alphabet Bayesian probabilistic approach for predicting backbone structures in terms of protein blocks, Infectious Diseases -Drug Targets Biochim Biophys Acta In Silico Biol Proteins, vol.171820, issue.41, pp.288-306, 2000. ,
A structural alphabet for local protein structures: Improved prediction methods, silico studies on DARC Antimalarial drug discovery: in silico structural biology and rational drug design, pp.810-827, 2005. ,
DOI : 10.1002/prot.20458
URL : https://hal.archives-ouvertes.fr/inserm-00143564
Computational Biology in Anti-Tuberculosis Drug Discovery, Infectious Disorders - Drug Targets, vol.9, issue.3, 2009. ,
DOI : 10.2174/1871526510909030319
New Approaches to Structure-Based Discovery of Dengue Protease Inhibitors, Infectious Diseases -Drug Targets, 27] SHARE, the journey: a European HealthGrid roadmap, printed by European Commission Information Society and Media DG, 2009. ,
Innovative in silico approaches to address avian flu using grid technology, Infectious Diseases -Drug Targets, 2009. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00441054
Interactive Text Mining with Pipeline Pilot: A Bibliographic Web-Based Tool for PubMed, Infectious Disorders - Drug Targets, vol.9, issue.3, 2009. ,
DOI : 10.2174/1871526510909030366